Design, synthesis and biological activity of novel chalcone derivatives as anti-influenza agents

Fangyuan Shi , Hao Fang , Wenfang Xu

Chemical Research in Chinese Universities ›› 2016, Vol. 32 ›› Issue (1) : 28 -34.

PDF
Chemical Research in Chinese Universities ›› 2016, Vol. 32 ›› Issue (1) : 28 -34. DOI: 10.1007/s40242-015-5356-z
Article

Design, synthesis and biological activity of novel chalcone derivatives as anti-influenza agents

Author information +
History +
PDF

Abstract

series of novel chalcone derivatives was designed and synthesized via a suitable synthetic strategy in good yields using commercially available 2-amino-4-nitrophenol as an initiator. The structures of the target compounds were confirmed by means of 1H NMR, 13C NMR and high-resolution mass spectrometry(HRMS). And the ability of the target compounds to inhibit influenza viruses was evaluated. These compounds showed moderate inhibitory activity against influenza A(H9N2 and H5N1) viruses. Within this series, compounds S14 and S15 with good potency(IC50=40.3―51.5 μmol/L) could be used as lead compounds in the future.

Keywords

Influenza virus / Inhibitor / Chalcone / Biological activity

Cite this article

Download citation ▾
Fangyuan Shi, Hao Fang, Wenfang Xu. Design, synthesis and biological activity of novel chalcone derivatives as anti-influenza agents. Chemical Research in Chinese Universities, 2016, 32(1): 28-34 DOI:10.1007/s40242-015-5356-z

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Pennisi E. Science, 1995, 270(5244): 1916.

[2]

Stevens J., Blixt O., Chen L. M., Donis R. O., Paulson J. C., Wilson I. A. Journal of Molecular Biology, 2008, 381(5): 1382.

[3]

de Wit E., Fouchier R. A. J. Clin. Virol., 2008, 41(1): 1.

[4]

Koopmans M., Wilbrink B., Conyn M., Natrop G., van der Nat H., Vennema H., Meijer A., van Steenbergen J., Fouchier R., Osterhaus A., Bosman A. Lancet, 2004, 363(9409): 587.

[5]

Lin Y. P., Shaw M., Gregory V., Cameron K., Lim W., Klimov A., Subbarao K., Guan Y., Krauss S., Shortridge K., Webster R., Cox N., Hay A. Proc. Natl. Acad. Sci. USA, 2000, 97(17): 9654.

[6]

Morton S. E., Mathai M., Byrd R. P. Jr., Fields C. L., Roy T. M. Southern Medical Journal, 2001, 94(1): 67.

[7]

Hay A. J., Wolstenholme A. J., Skehel J. J., Smith M. H. The Journal, 1985, 4(11): 3021.

[8]

Mendel D. B., Tai C. Y., Escarpe P. A., Li W., Sidwell R. W., Huffman J. H., Sweet C., Jakeman K. J., Merson J., Lacy S. A., Lew W., Williams M. A., Zhang L., Chen M. S., Bischofberger N., Kim C. U. Antimicrobial Agents and Chemotherapy, 1998, 42(3): 640.

[9]

Deyde V. M., Xu X., Bright R. A., Shaw M., Smith C. B., Zhang Y., Shu Y., Gubareva L. V., Cox N. J., Klimov A. I. The Journal of Infectious Diseases, 2007, 196(2): 249.

[10]

de Jong M. D., Tran T. T., Truong H. K., Vo M. H., Smith G. J., Nguyen V. C., Bach V. C., Phan T. Q., Do Q. H., Guan Y., Peiris J. S., Tran T. H., Farrar J. The New England Journal of Medicine, 2005, 353(25): 2667.

[11]

Lackenby A., Hungnes O., Dudman S. G., Meijer A., Paget W. J., Hay A. J., Zambon M. C. Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles(European Communicable Disease Bulletin), 2008, 13(5): 1.

[12]

Liu A. L., Wang H. D., Lee S. M., Wang Y. T., Du G. H. Bioorganic & Medicinal Chemistry, 2008, 16(15): 7141.

[13]

Upadhyay A., Chompoo J., Taira N., Fukuta M., Gima S., Tawata S. Journal of Agricultural and Food Chemistry, 2011, 59(24): 12858.

AI Summary AI Mindmap
PDF

104

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/